fingolimod has been researched along with Disease Models, Animal in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, G; Elliott, JD; Guo, TB; Jia, Q; Li, C; Lin, X; Lu, H; Luan, L; Meng, Q; Ren, F; Wang, H; Xiang, JN; Xu, H; Xu, Q; Xu, X; Yang, J; Zhang, H; Zhang, W; Zhao, B; Zhao, Y | 1 |
| Al-Shamma, H; Barden, J; Buzard, DJ; Calderon, I; Chen, C; Edwards, J; Espinola, S; Fu, L; Gao, Y; Gatlin, J; Gharbaoui, T; Han, S; Jones, RM; Kawasaki, A; Krishnan, A; Le, M; Lehmann, J; Liu, L; Lopez, L; Moody, J; Morgan, M; Sadeque, A; Sengupta, D; Solomon, M; Thatte, J; Thoresen, L; Ullman, B; Usmani, K; Whelan, K; Xing, C; Zhu, X | 1 |
| Amaudrut, J; Argiriadi, MA; Barth, M; Breinlinger, EC; Bressac, D; Broqua, P; Calderwood, DJ; Chatar, M; Cusack, KP; Gauld, SB; Jacquet, S; Kamath, RV; Kort, ME; Lepais, V; Luccarini, JM; Masson, P; Montalbetti, C; Mounier, L; Potin, D; Poupardin, O; Rouaud, S; Spitzer, L; Wallace, CD | 1 |
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
4 other study(ies) available for fingolimod and Disease Models, Animal
| Article | Year |
|---|---|
Discovery of novel 1,2,4-thiadiazole derivatives as potent, orally active agonists of sphingosine 1-phosphate receptor subtype 1 (S1P(1)).
Topics: Administration, Oral; Animals; Blood-Brain Barrier; Brain; Disease Models, Animal; Humans; Immunosuppressive Agents; Lymphocyte Count; Lymphocytes; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Inbred C57BL; Multiple Sclerosis, Relapsing-Remitting; Rats; Receptors, Lysosphingolipid; Specific Pathogen-Free Organisms; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship; Thiadiazoles | 2012 |
Fused tricyclic indoles as S1P₁ agonists with robust efficacy in animal models of autoimmune disease.
Topics: Animals; Autoimmune Diseases; Disease Models, Animal; Female; Humans; Immunologic Factors; Indoles; Lymphocytes; Male; Mice; Mice, Inbred C57BL; Microsomes; Rats; Rats, Sprague-Dawley; Receptors, Lysosphingolipid; Structure-Activity Relationship | 2012 |
Discovery of novel quinoline sulphonamide derivatives as potent, selective and orally active RORγ inverse agonists.
Topics: Animals; Disease Models, Animal; Drug Inverse Agonism; Humans; Mice; Nuclear Receptor Subfamily 1, Group F, Member 3; Quinolines | 2019 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |